• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

RO:SW

269.50 CHF 0.25 0.09%

As of 11:31:18 ET on 10/24/2014.

Snapshot for Roche Holding AG (RO)

Open: 269.50 Day's Range: 267.50 - 270.50 Volume: 13,262
Previous Close: 269.75 52wk Range: 229.70 - 278.50 1-Yr Rtn: +11.95%

Stock Chart for RO

No chart data available.
  • RO:SW 269.50
  • 1D
  • 1M
  • 1Y
269.75
Interactive RO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RO

Current P/E Ratio (ttm) 21.2539
Estimated P/E(12/2014) 18.2181
Relative P/E vs. SMI 1.1078
Earnings Per Share (CHF) (ttm) 12.6800
Est. EPS (CHF) (12/2014) 14.7930
Est. PEG Ratio 3.1078
Market Cap (M CHF) 238,432.43
Shares Outstanding (M) 160.00
30 Day Average Volume 32,215
Price/Book (mrq) 13.1430
Price/Sale (ttm) 4.9162
Dividend Indicated Gross Yield 2.89%
Cash Dividend (CHF) 7.8000
Dividend Ex-Date 03/06/2014
5 Year Dividend Growth 9.30%
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RO

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RO

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil